These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3578177)

  • 1. Prolactinoma in children.
    Rohn R
    Am J Dis Child; 1987 Jun; 141(6):600-1. PubMed ID: 3578177
    [No Abstract]   [Full Text] [Related]  

  • 2. Increased micronucleus, nucleoplasmic bridge, nuclear bud frequency and oxidative DNA damage associated with prolactin levels and pituitary adenoma diameters in patients with prolactinoma.
    Bitgen N; Donmez-Altuntas H; Bayram F; Cakir I; Hamurcu Z; Diri H; Baskol G; Senol S; Durak AC
    Biotech Histochem; 2016; 91(2):128-36. PubMed ID: 26720589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Occurrence of prolactinoma after estrogen treatment in a girl with constitutional tall stature.
    Panteon E; Loumaye E; Maes M; Malvaux P
    J Pediatr; 1988 Aug; 113(2):337-9. PubMed ID: 3397798
    [No Abstract]   [Full Text] [Related]  

  • 4. Giant prolactinoma: where's the prolactin?
    Tailor C; Teo I; Sorisky A
    Clin Neurol Neurosurg; 2011 Nov; 113(9):810-2. PubMed ID: 21906866
    [No Abstract]   [Full Text] [Related]  

  • 5. Calmodulin content in human prolactin-secreting pituitary adenoma: an inverse relationship to serum prolactin levels.
    Bridges AJ; Ho AK
    Neurosci Lett; 1988 Jul; 90(1-2):224-8. PubMed ID: 3412646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolactin secreting pituitary carcinoma.
    Petterson T; MacFarlane IA; MacKenzie JM; Shaw MD
    J Neurol Neurosurg Psychiatry; 1992 Dec; 55(12):1205-6. PubMed ID: 1479402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term treatment of prolactin-secreting macroadenomas with pergolide.
    Freda PU; Andreadis CI; Khandji AG; Khoury M; Bruce JN; Jacobs TP; Wardlaw SL
    J Clin Endocrinol Metab; 2000 Jan; 85(1):8-13. PubMed ID: 10634356
    [No Abstract]   [Full Text] [Related]  

  • 8. Does bromocriptine have a cytocidal effect on prolactinoma cells? Report of a case.
    Gen M; Uozumi T; Shinohara S; Naito M; Ito A; Mori S; Kajiwara H
    Neurol Med Chir (Tokyo); 1983 Jan; 23(1):61-5. PubMed ID: 6188984
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical evaluation of large prolactinoma (author's transl)].
    Matsumura S; Mori S; Ohta M; Uozumi T; Takimoto N; Watanabe M; Ohnishi T; Kumahara Y; Miyai K
    Neurol Med Chir (Tokyo); 1979 Nov; 19(11):1107-13. PubMed ID: 93251
    [No Abstract]   [Full Text] [Related]  

  • 10. Microsurgical management of prolactinomas - clinical and hormonal outcomes.
    Vivekanandan S; Nayak D
    Neurol India; 2011; 59(6):944-5. PubMed ID: 22234233
    [No Abstract]   [Full Text] [Related]  

  • 11. Craniopharyngioma with hyperprolactinaemia due to a prolactinoma.
    Wheatley T; Clark JD; Stewart S
    J Neurol Neurosurg Psychiatry; 1986 Nov; 49(11):1305-7. PubMed ID: 3794737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microprolactinoma and large prolactinoma: are they two different diseases.
    Al-Mefty O; Woodhouse N
    Neurosurgery; 1985 Aug; 17(2):379. PubMed ID: 4033891
    [No Abstract]   [Full Text] [Related]  

  • 13. Galactorrhoea following hypophysectomy in a boy with a prolactinoma.
    Dandona P; Mohiuddin J; Lindsay KW
    Postgrad Med J; 1984 Aug; 60(706):540-1. PubMed ID: 6540876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interrelationship between TSH- and prolactin secretion in patients with prolactinoma and autoimmune thyroiditis.
    Pelkonen R; Salmi J; Lamberg BA
    Acta Endocrinol (Copenh); 1982 Jun; 100(2):184-8. PubMed ID: 6810613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cystic prolactinoma of the pituitary following surgery for polycystic ovaries.
    Kurisaka M; Tindall SC; Takei Y
    Neurol Med Chir (Tokyo); 1983 Jan; 23(1):55-60. PubMed ID: 6188983
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prolactin producing pituitary tumor].
    Miyachi Y; Katayanagi N; Yamamoto N; Shimojo M
    Nihon Rinsho; 2001 Dec; 59 Suppl 8():12-6. PubMed ID: 11808216
    [No Abstract]   [Full Text] [Related]  

  • 17. ALK7 expression in prolactinoma is associated with reduced prolactin and increased proliferation.
    Principe M; Chanal M; Karam V; Wierinckx A; Mikaélian I; Gadet R; Auger C; Raverot V; Jouanneau E; Vasiljevic A; Hennino A; Raverot G; Bertolino P
    Endocr Relat Cancer; 2018 Sep; 25(9):795-806. PubMed ID: 30012586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of the elution pattern of the serum and CSF prolactin fractionated by gel filtration chromatography in cases of bromocriptine-resistant prolactinoma].
    Sakamoto T; Kowada M; Hasegawa H; Ishino Y; Mineura K; Wakisaka A; Fukushima M
    Neurol Med Chir (Tokyo); 1987 Mar; 27(3):195-201. PubMed ID: 2442642
    [No Abstract]   [Full Text] [Related]  

  • 19. Characterization of a tissue kallikrein in human prolactin-secreting adenomas.
    Jones TH; Figueroa CD; Smith C; Cullen DR; Bhoola KD
    J Endocrinol; 1990 Feb; 124(2):327-31. PubMed ID: 2313220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Characteristics of male prolactinoma and problems in management (author's transl)].
    Watanabe M; Kuwayama A; Nakane T; Takanohashi M; Takahashi T; Kanie N; Kageyama N
    Neurol Med Chir (Tokyo); 1982 May; 22(5):369-77. PubMed ID: 6180338
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.